TickerFactsScreenerDevelopers

LEXICON PHARMACEUTICALS, INC. (LXRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $85.87M2009: $100.55M2010: $47.21M2011: $186.31M2012: $30.42M2013: $37.50M2014: $137.27M2015: $202.99M2016: $46.60M2017: $61.66M2018: $80.39M2019: $36.11M2020: $126.26M2021: $64.06M2022: $46.34M2023: $22.46M2024: $66.66M2025: $34.33M$34.33M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$34.33M-48.5%
2024$66.66M+196.7%
2023$22.46M-51.5%
2022$46.34M-27.7%
2021$64.06M-49.3%
2020$126.26M+249.6%
2019$36.11M-55.1%
2018$80.39M+30.4%
2017$61.66M+32.3%
2016$46.60M-77.0%
2015$202.99M+47.9%
2014$137.27M+266.1%
2013$37.50M+23.3%
2012$30.42M-83.7%
2011$186.31M+294.7%
2010$47.21M-53.1%
2009$100.55M+17.1%
2008$85.87M—